Bryce Vissel

384 Victoria Street
Sydney, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.

Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.

Journal: Journal of Alzheimer's disease : JAD

Published: July 23, 2026

Serious side effects of Alzheimer's immunotherapy demand scrutiny.

Serious side effects of Alzheimer's immunotherapy demand scrutiny.

Journal: Ageing research reviews

Published: April 09, 2026

Intracerebroventricular diphtheria toxin causes off-target toxicity in CD11b-DTR and wild-type mice, revealing limitations of DTR-based depletion studies.

Intracerebroventricular diphtheria toxin causes off-target toxicity in CD11b-DTR and wild-type mice, revealing limitations of DTR-based depletion studies.

Journal: Frontiers in neuroscience

Published: February 07, 2026

Anti-amyloid antibodies for Alzheimer's disease are not truly disease modifying.

Anti-amyloid antibodies for Alzheimer's disease are not truly disease modifying.

Journal: BMJ (Clinical research ed.)

Published: January 09, 2026

Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway.

Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway.

Journal: Scientific reports

Published: August 25, 2025

Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters.

Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters.

Journal: Frontiers in pharmacology

Published: August 10, 2025

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

Journal: PloS one

Published: May 14, 2025

Toward the development of a sporadic model of Alzheimer's disease: comparing pathologies between humanized APP and the familial J20 mouse models.

Toward the development of a sporadic model of Alzheimer's disease: comparing pathologies between humanized APP and the familial J20 mouse models.

Journal: Frontiers in aging neuroscience

Published: April 23, 2024

Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.

Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.

Journal: Ageing research reviews

Published: April 10, 2024

Modeling sporadic Alzheimer's disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors.

Modeling sporadic Alzheimer's disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors.

Journal: Frontiers in aging neuroscience

Published: December 18, 2023

Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer's disease by capillary western blotting.

Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer's disease by capillary western blotting.

Journal: Frontiers in molecular neuroscience

Published: November 14, 2023

Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.

Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.

Journal: Ageing research reviews

Published: October 31, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026